| Financial Year |
March 31 2023 |
| Monetary Funds |
361,972,725.17 |
| Held-for-trading Financial Assets |
51,356,000.00 |
| Notes Receivable |
12,318,509.55 |
| Accounts Receivable |
1,626,329,157.76 |
| Advances to Suppliers |
196,267,589.80 |
| Other Receivables |
45,158,808.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
894,751,146.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,868,635.99 |
| Total Current Assets |
3,225,473,587.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
79,644,391.60 |
| Investment Properties |
-- |
| Fixed Assetes |
59,170,851.77 |
| Under-construction Projects |
201,981,504.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
195,730,456.57 |
| R&D expenses |
103,750,562.17 |
| Goodwill |
12,979,819.05 |
| Long-Term Deferred and Prepaid Expenses |
694,303.63 |
| Deferred Income Tax Assets |
69,348,966.67 |
| Other Non-Current Assets |
10,990,985.45 |
| Sub-Total of Non-Current Assets |
750,208,918.55 |
| Total Assets |
3,975,682,506.03 |
| Short-Term Loans |
721,414,219.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,177,210.08 |
| Accounts Payable |
498,993,066.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,284,174.99 |
| Taxes Payable |
42,593,162.50 |
| Interest Payable |
-- |
| Dividend Payable |
3,451,109.61 |
| Other payables |
35,941,139.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,091,528.04 |
| Other Current Liabilities |
21,805,384.21 |
| Sub-Total of Current Liabilities |
1,528,151,344.94 |
| Long-term Loans |
150,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
78,359.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,315,608.31 |
| Deferred Income Tax Liabilities |
2,154,447.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
165,724,965.43 |
| Total Liabilities |
1,693,876,310.37 |
| Paid-In Capital(Or Share Stock) |
607,576,150.00 |
| Capital Surplus |
2,439,439,324.79 |
| Surplus Reserve |
51,440,654.21 |
| LESS:Treasury Stock |
44,852,639.17 |
| Undistributed Profits |
-621,659,820.76 |
| Minority Stockholder's Interest |
-152,457,953.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,434,264,149.00 |
| Owner's Equity（Stockholder's Equity） |
2,281,806,195.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,975,682,506.03 |
